Literature DB >> 20739496

Neisseria meningitidis serogroup X sequence type 767 in Turkey.

Abdullah Kiliç, Orhan Bedir, A Celal Basustaoglu, Holly B Bratcher, Keith A Jolley, Gurkan Mert.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20739496      PMCID: PMC3020828          DOI: 10.1128/JCM.01417-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  13 in total

1.  A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China.

Authors:  Chao Chen; Tie-gang Zhang; Jing-guo He; Jiang Wu; Li-juan Chen; Jun-feng Liu; Xing-huo Pang; Jie Yang; Zhu-jun Shao; Ying-chun Huang
Journal:  Chin Med J (Engl)       Date:  2008-04-05       Impact factor: 2.628

2.  Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.

Authors:  G Campagne; A Schuchat; S Djibo; A Ousséini; L Cissé; J P Chippaux
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

3.  Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain.

Authors:  A Domínguez; N Cardeñosa; C Izquierdo; F Sánchez; N Margall; J A Vázquez; L Salleras
Journal:  Epidemiol Infect       Date:  2001-12       Impact factor: 2.451

4.  Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.

Authors:  Sébastien P Gagneux; Abraham Hodgson; Tom A Smith; Thierry Wirth; Ingrid Ehrhard; Giovanna Morelli; Blaise Genton; Fred N Binka; Mark Achtman; Gerd Pluschke
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

5.  Clonal groupings in serogroup X Neisseria meningitidis.

Authors:  Sébastien Gagneux; Thierry Wirth; Abraham Hodgson; Ingrid Ehrhard; Giovanna Morelli; Paula Kriz; Blaise Genton; Tom Smith; Fred Binka; Gerd Pluschke; Mark Achtman
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

6.  Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization.

Authors:  G R Jones; M Christodoulides; J L Brooks; A R Miller; K A Cartwright; J E Heckels
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

7.  [Genotypic characteristics of Neisseria meningitidis serogroup W-135 strains isolated as the agent of fatal meningitis in a military hospital].

Authors:  Abdullah Kiliç; Keith A Jolley; Bülent Beşirbellioğlu; Nafiz Koçak; Orhan Bedir; Can Polat Eyigün; Ahmet Celal Başustaoğlu
Journal:  Mikrobiyol Bul       Date:  2009-07       Impact factor: 0.622

8.  Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980.

Authors:  D Hansman
Journal:  J Hyg (Lond)       Date:  1983-02

9.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Serogroup X in meningococcal disease, Western Kenya.

Authors:  Sadiki Materu; Helen S Cox; Petros Isaakidis; Bienvenu Baruani; Thomas Ogaro; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more
  2 in total

1.  Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case.

Authors:  Gönül Tanır; Yasemin Ozsurekci; Jay Lucidarme; Sevgi Yaşar Durmuş; Aiswarya Lekshmi; Özlem Akisoglu; Ahmet Emre Aycan; Ray Borrow; Mehmet Ceyhan
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

2.  An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.

Authors:  Timm Fiebig; Maria Rosaria Romano; Davide Oldrini; Roberto Adamo; Marta Tontini; Barbara Brogioni; Laura Santini; Monika Berger; Paolo Costantino; Francesco Berti; Rita Gerardy-Schahn
Journal:  NPJ Vaccines       Date:  2016-11-15       Impact factor: 7.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.